Mycophenolate Pharmacokinetics in Calcineurin Inhibitor-Free, Corticosteroid-Free Renal Transplant Recipients.

被引：0
|
作者：
Revollo, J. [1 ]
Mizuno, T. [2 ]
Fukuda, T. [2 ]
Tremblay, S. [1 ]
Mogilishetty, G. [1 ]
Shields, A. [3 ]
Vinks, A. [2 ]
Woodle, E. [1 ]
Alloway, R. [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[3] Christ Hosp, Cincinnati, OH 45219 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01845
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
B1001
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [41] Concomitant Proton Pump Inhibitor and Mycophenolate Mofetil Use in Renal Transplant Recipients.
    Patel, K.
    Stephany, B.
    Barnes, J.
    Bauer, S.
    Spinner, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 784 - 784
  • [42] Long-term effects of a calcineurin-inhibitor-free immunosuppression with mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy
    Malyar, Viola
    Hohage, Helge
    Gerhardt, Ulf
    Suwelack, Barbara
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 396 - 396
  • [43] Excellent results with calcineurin inhibitor-free initial immunosuppression in old recipients of old kidneys
    Bösmüller, C
    Öllinger, R
    Mark, W
    Brandacher, G
    Schneeberger, S
    Cakar, F
    Bonatti, H
    Margreiter, R
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 881 - 883
  • [44] The renal benefit of calcineurin inhibitor-free immunosuppression after heart transplantation: Is it safe?
    Kobashigawa, JA
    Patel, JK
    Marquez, A
    Oeser, BT
    Moriguchi, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 193A - 193A
  • [45] Impact of calcineurin inhibitor-free immunosuppression on de novo donor-specific antibody formation in liver transplant recipients
    Meszaros, Magdalena
    Dubois, Valerie
    Congy-Jolivet, Nicolas
    Hamada, Sarah
    Thevenin, Celine
    Faure, Stephanie
    Boillot, Olivier
    Kamar, Nassim
    Pageaux, Georges-Philippe
    Del Bello, Arnaud
    Dumortier, Jerome
    LIVER INTERNATIONAL, 2022, 42 (05) : 1132 - 1143
  • [46] ACUTE REJECTION FEATURES IN DUAL KIDNEY TRANSPLANT RECIPIENTS FROM ELDERLY DONORS: COMPARISON OF CALCINEURIN INHIBITOR-BASED AND CALCINEURIN INHIBITOR-FREE IMMUNOSUPPRESSIVE PROTOCOLS
    Aiello, F. B.
    Furian, L.
    Marino, S.
    Marchini, F.
    Cardillo, M.
    De Fazio, N.
    Rigotti, P.
    Valente, M.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (04) : 1001 - 1007
  • [47] Conversion from sirolimus to everolimus in maintenance renal transplant recipients within a calcineurin inhibitor-free regimen: results of a 6-month pilot study
    Kamar, N.
    Jaafar, A.
    Esposito, L.
    Ribes, D.
    Durand, D.
    Di-Giambattista, F.
    Tack, I.
    Rostaing, L.
    CLINICAL NEPHROLOGY, 2008, 70 (02) : 118 - 125
  • [48] Withdrawal of Mycophenolate Mofetil in stable renal transplant recipients.
    Meier-Kriesche, HU
    Kaza, H
    Thambuganipalle, R
    Vaghela, M
    Jacobs, HG
    Mulgaonkar, SP
    Friedman, GS
    Kaplan, B
    TRANSPLANTATION, 2000, 69 (08) : S132 - S132
  • [49] Cyclosporin changes the pharmacokinetics of mycophenolate mofetil in kidney transplant recipients.
    Gregoor, PJHS
    Hesse, CJ
    van der Mast, BJ
    IJzermans, JNM
    Weimar, W
    van Gelder, T
    KIDNEY INTERNATIONAL, 1999, 55 (03) : 1164 - 1164
  • [50] Evaluation of Mycophenolate Mofetil Exposure in Renal Transplant Recipients.
    Ott, M. C.
    Mietz, S.
    Chang, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1109 - 1109
12345